Laboratorios IMA

Laboratorios IMA is an Argentine pharmaceutical company specializing in the development and manufacture of high-complexity medicines, with a primary focus on oncology and onco-hematology. Founded in 1960, the company operates a specialized manufacturing plant in Buenos Aires dedicated to the production of cytotoxic and lyophilized products. In 2011, it was acquired by the Brazilian pharmaceutical group Cristália, which expanded its regional footprint and R&D capabilities. Laboratorios IMA provides a wide range of generic and specialized injectable treatments used in hospitals and clinics across Latin America. The company is recognized for its expertise in sterile manufacturing and its commitment to providing accessible high-quality treatments for complex diseases.